Literature DB >> 906778

25-hydroxycholecalciferol serum levels in patients with Crohn's disease.

A Sonnenberg, H Ehms, G E Sonnenberg, G Strohmeyer.   

Abstract

In 37 patients with Crohn's disease the 25-hydroxycholecalciferol (25-HCC) serum level, serum concentration of calcium and inorganic phosphate, and the enzyme activity of alkaline phosphatase were measured. Furthermore the activity index of Crohn's disease was determined in every patient. There was no statistically significant difference of 25-HCC serum levels in these patients compared to a healthy control group. Correspondingly most patients showed normal alkaline phosphatase enzyme activity and normal serum concentration of calcium and inorganic phosphate. No correlation between 25-HCC concentration and site of inflammation or activity index was found.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 906778

Source DB:  PubMed          Journal:  Acta Hepatogastroenterol (Stuttg)        ISSN: 0300-970X


  6 in total

Review 1.  Nutritional disturbances in Crohn's disease.

Authors:  A D Harries; R V Heatley
Journal:  Postgrad Med J       Date:  1983-11       Impact factor: 2.401

Review 2.  Clinical relevance of changes in bone metabolism in inflammatory bowel disease.

Authors:  Pal Miheller; Katalin Lorinczy; Peter-Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

3.  Vitamin D status in Crohn's disease: association with nutrition and disease activity.

Authors:  A D Harries; R Brown; R V Heatley; L A Williams; S Woodhead; J Rhodes
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

4.  Bone disease in vitamin D-deficient patients with Crohn's disease.

Authors:  H Vogelsang; P Ferenci; W Woloszczuk; H Resch; C Herold; S Frotz; A Gangl
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

Review 5.  Vitamin D and inflammatory bowel disease.

Authors:  Marco Ardesia; Guido Ferlazzo; Walter Fries
Journal:  Biomed Res Int       Date:  2015-04-27       Impact factor: 3.411

6.  The early onset of disease may be a risk factor for decreased bone mineral density in patients with inflammatory bowel disease.

Authors:  Hwa Jong Kim; Su Jin Hong; Young Woo Jeon; Jae Pil Han; Seung Hyo Han; Jee Heon Kang; Jae Woong Tae; Hee Sook Lim; Hee Kyung Kim; Bong Min Ko; Moon Sung Lee
Journal:  Clin Endosc       Date:  2013-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.